Companies: 10,795·Total market cap: $144.5T
PLx Pharma Inc.

PLx Pharma Inc.

PLXPNASDAQHealthcare
$0.09
+$0.00(+0.00%)
Market Cap$2534980
P/E Ratio
52W High$3.41
52W Low$0.009
Overview

PLx Pharma Inc. (PLXP) Insider Trading

Form 4 buy vs sell counts, ratio, and sentiment — switch this quarter or last 12 months; chart and transactions below.

SEC EDGAR · FMP · PLXP · as of Jun 9, 2026

Activity summary

Buy transactions

12

P-Purchase only

Sell transactions

0

12 Months

Buy/Sell ratio

Buy/Sell (by trades)

Overall sentiment

BULLISH
↑ Buy 100%Active transactions only · RSU vesting excluded0% Sell ↓

PLx Pharma Inc. insiders have been net buyers of shares over the past 12 Months, which may signal confidence in the company's outlook.

Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · Buy = P-Purchase only · Sell = S-Sale only

As of Jun 9, 2026

PLXP insider buying and selling by quarter

PLXP insider selling · PLXP insider buying stocks · quarterly insider activity

Total insider buying (incl. awards)Total insider selling
1.5M726K0
2021 Q1
2021 Q2
2021 Q3
2022 Q1

Mobile shows last 4Q · Desktop shows full 8Q

Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · last 8 quarters

As of Jun 9, 2026

Recent insider transactions

PLXP executive sell shares · PLXP board member insider trading · PLXP insider trading SEC filing

Showing 36 most recent · Common Stock · Form 4 only

Scroll horizontally to see all columns

Giordano Natasha

CEO

Purchase

Date

Mar 15

Shares

4,100

Price

$3.65

Value

$15K

View Form 4 on SEC.gov

O'Connor Rita M

CFO

Purchase

Date

Mar 15

Shares

3,700

Price

$3.65

Value

$14K

View Form 4 on SEC.gov

O'Connor Rita M

CFO

Purchase

Date

Mar 15

Shares

10,000

Price

$3.66

Value

$37K

View Form 4 on SEC.gov

Valentino Michael J

Executive Chairman · Director

Purchase

Date

Jun 14

Shares

120

Price

$12.51

Value

$2K

View Form 4 on SEC.gov

Valentino Michael J

Executive Chairman · Director

Purchase

Date

Jun 14

Shares

5,080

Price

$12.50

Value

$64K

View Form 4 on SEC.gov

Valentino Michael J

Executive Chairman · Director

Purchase

Date

Jun 14

Shares

100

Price

$12.48

Value

$1K

View Form 4 on SEC.gov

Valentino Michael J

Executive Chairman · Director

Purchase

Date

Jun 14

Shares

300

Price

$12.47

Value

$4K

View Form 4 on SEC.gov

Valentino Michael J

Executive Chairman · Director

Purchase

Date

Jun 14

Shares

600

Price

$12.47

Value

$7K

View Form 4 on SEC.gov

Valentino Michael J

Executive Chairman · Director

Purchase

Date

Jun 14

Shares

100

Price

$12.46

Value

$1K

View Form 4 on SEC.gov

Valentino Michael J

Executive Chairman · Director

Purchase

Date

Jun 14

Shares

100

Price

$12.45

Value

$1K

View Form 4 on SEC.gov

Valentino Michael J

Executive Chairman · Director

Purchase

Date

Jun 14

Shares

400

Price

$12.45

Value

$5K

View Form 4 on SEC.gov

Valentino Michael J

Executive Chairman · Director

Purchase

Date

Jun 14

Shares

1,200

Price

$12.44

Value

$15K

View Form 4 on SEC.gov

Valentino Michael J

Executive Chairman · Director

Purchase

Date

Mar 5

Shares

25,000

Price

$8.00

Value

$200K

View Form 4 on SEC.gov

HADDEN JOHN

Director

Purchase

Date

Dec 14

Shares

400

Price

$5.49

Value

$2K

View Form 4 on SEC.gov

HADDEN JOHN

Director

Purchase

Date

Dec 14

Shares

600

Price

$5.42

Value

$3K

View Form 4 on SEC.gov

HADDEN JOHN

Director

Purchase

Date

Nov 25

Shares

500

Price

$5.48

Value

$3K

View Form 4 on SEC.gov

Valentino Michael J

Executive Chairman · Director

Purchase

Date

Nov 18

Shares

264,900

Price

$3.79

Value

$1.00M ⚡

View Form 4 on SEC.gov

O'Connor Rita M

CFO

Purchase

Date

Sep 2

Shares

2,120

Price

$3.83

Value

$8K

View Form 4 on SEC.gov

O'Connor Rita M

CFO

Purchase

Date

Sep 1

Shares

4,500

Price

$3.74

Value

$17K

View Form 4 on SEC.gov

O'Connor Rita M

CFO

Purchase

Date

Aug 21

Shares

4,050

Price

$3.97

Value

$16K

View Form 4 on SEC.gov

O'Connor Rita M

CFO

Purchase

Date

Aug 20

Shares

2,300

Price

$3.77

Value

$9K

View Form 4 on SEC.gov

Valentino Michael J

Executive Chairman · Director

Purchase

Date

May 20

Shares

44,404

Price

$5.60

Value

$249K

View Form 4 on SEC.gov

Valentino Michael J

Executive Chairman · Director

Award

Date

Aug 10

Shares

30,000

Price

Value

View Form 4 on SEC.gov

JORDEN DAVID EMERSON

Acting Chief Financial Officer

Purchase

Date

Jun 14

Shares

32,727

Price

$6.88

Value

$225K

View Form 4 on SEC.gov

MOSSMAN GARY L

COO

Purchase

Date

Jun 14

Shares

7,273

Price

$6.88

Value

$50K

View Form 4 on SEC.gov

⚡ = value ≥ $1M · Award/Option price shows — · formType=4 · securityName=Common Stock · url → sec.gov/Archives/edgar

1 / 2

Source: SEC EDGAR · Form 4 filings · ⚡ = value ≥ $1M · Award/Option price shows —

About PLXP insider trading

PLXP insider trades

PLx Pharma Inc. (PLXP) insider trading data is sourced from SEC Form 4 filings submitted by corporate insiders, including PLXP. Over the past 12 months, 0 insiders have filed transactions with the SEC. PLXP insiders have been primarily buying, which may reflect pre-scheduled Rule 10b5-1 plan executions.

For PLx Pharma Inc.'s institutional ownership breakdown and insider ownership percentage, see the Ownership tab → Ownership tab →

Buy/Sell signal logic
acquisitionOrDisposition field:
A = Acquisition (buy) · D = Disposition (sell)
RSU vesting (M-Exempt) excluded from sentiment
Form 4SEC filing required within 2 business days of any insider transaction
10b5-1Pre-scheduled trading plan that allows insiders to sell on autopilot
Open MktDirect purchase or sale on the open market (excludes awards, options)

Frequently asked questions

PLXP insider trading · 5 questions

The insiders of PLx Pharma Inc. (PLXP) include executives and directors such as PLXP, among others. Over the past 12 months, 0 insiders have filed Form 4 transactions with the SEC. Insider transactions are required to be reported within 2 business days of the trade date.

PLXP board member insider tradingwho are PLXP insidersPLXP insider rosterPLx Pharma Inc. executives insider activity

Source: FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · acquisitionOrDisposition A=Buy, D=Sell · RSU vesting (M-Exempt) excluded from sentiment bar · As of Jun 9, 2026